David-Alexandre C. Gros
2016 - Alnylam Pharmaceuticals
In 2016, David-Alexandre C. Gros earned a total compensation of $1.3M as Former Senior Vice President, Chief Business Officer former principal financial officer at Alnylam Pharmaceuticals, a 87% decrease compared to previous year.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Non-Equity Incentive Plan | $138,336 |
| Option Awards | $620,958 |
| Salary | $432,300 |
| Other | $1,610 |
| Total | $1,293,204 |
Gros received $621K in option awards, accounting for 48% of the total pay in 2016.
Gros also received $100K in bonus, $138.3K in non-equity incentive plan, $432.3K in salary and $1.6K in other compensation.
Rankings
In 2016, David-Alexandre C. Gros' compensation ranked 6,993rd out of 14,075 executives tracked by ExecPay. In other words, Gros earned more than 50.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,993 out of 14,075 | 50th |
Division Manufacturing | 2,625 out of 5,488 | 52nd |
Major group Chemicals And Allied Products | 857 out of 1,900 | 55th |
Industry group Drugs | 659 out of 1,543 | 57th |
Industry Pharmaceutical Preparations | 523 out of 1,173 | 55th |
Source: SEC filing on March 23, 2018.
Gros' colleagues
We found five more compensation records of executives who worked with David-Alexandre C. Gros at Alnylam Pharmaceuticals in 2016.
2016
Yvonne Greenstreet
Alnylam Pharmaceuticals
Chief Operating Officer
2016
John Maraganore
Alnylam Pharmaceuticals
Chief Executive Officer
2016
Akshay Vaishnaw
Alnylam Pharmaceuticals
President, Research and Development
2016
Barry Greene
Alnylam Pharmaceuticals
President
2016
Michael Mason
Alnylam Pharmaceuticals